White Paper

Decentralized clinical trials: From evolution to revolution

Part one of a three-part series on decentralized clinical trials

The life sciences industry made great progress in modernizing clinical research in response to COVID, but how can we ensure this momentum continues? In this paper, we'll explore the evolution of innovation in clinical research in recent years, including the challenges sponsors face adopting new approaches and the positive impact of modernization and decentralized trials. Then we'll take a close look at what will be required from the industry to enable widespread disruption of clinical research and a vision for the future.